Clinical Trial Update: A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update for apatinib tablets in advanced or metastatic gastric cancer, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 4 | Status: COMPLETED